Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gary Gordon, M.D.
Abbott
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
234 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Westmead Public Hospital
Westmead, New South Wales, Australia
- Royal Brisbane Hospital
Herston, Queensland, Australia
- Repatriation General Hospital
Daws Park, South Australia, Australia
- Peter Maccallum Cancer Institute
East Melbourne, Victoria, Australia
- Bayside Urology
Mentone, Victoria, Australia
- Royal Melbourne Hospital
Parkville, Victoria, Australia
- Princess Alexandra Hospital
Woolloongabba, Australia
- A. Ö. Krankenhaus Mistelbach
Mistelbach, Austria
- Klinik Fur Urologie Der Universitat Wien
Vienna, Austria
- A.Z. Middelheim
Antwerp, Belgium
- A Z St Jan
Bruges, Belgium
- University Hospital Erasme
Brussels, Belgium
- Uz Gent
Ghent, Belgium
- Private Practice Dr.Vekemans
Hasselt, Belgium
- C.H.U. Liege
Liège, Belgium
- St-Elisabeth Ziekenhuis
Turnhout, Belgium
- Tom Baker Cancer Center
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Wilson Urology
Kelowna, British Columbia, Canada
- Dr. Cal Andreou
Surrey, British Columbia, Canada
- Vancouver Hospital & Health Sciences Centre
Vancouver, British Columbia, Canada
- Dr. Gary Steinhoff, Clinical Research
Victoria, British Columbia, Canada
- Dr. P. J. Pommerville, Inc.
Victoria, British Columbia, Canada
- Abbott Clinic
Winnipeg, Manitoba, Canada
- Professional Corporation
Fredericton, New Brunswick, Canada
- Queen Elizabeth Ii Health Sciences Center
Halifax, Nova Scotia, Canada
- Valley Professional Centre
Kentville, Nova Scotia, Canada
- the Male Health Centres
Barrie, Ontario, Canada
- the Urology Resource Centre
Burlington, Ontario, Canada
- Northeastern Ontario Regional Cancer Centre
Greater Sudbury, Ontario, Canada
- Hamilton & District Urology Association
Hamilton, Ontario, Canada
- Kingston General Hospital
Kingston, Ontario, Canada
- Probidity Medical Research
Kitchener, Ontario, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Quest Clinical Trials
Markham, Ontario, Canada
- Walk-in Clinic
North Bay, Ontario, Canada
- Jack Barkin, M.D.
North York, Ontario, Canada
- the Male Health Centres
Oakville, Ontario, Canada
- Ottawa Hospital Civic Campus
Ottawa, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2001
- Primary completion
- —
- Completion
- —
- Last update posted
- 15 Aug 2007
- Registered enrollment
- 941
- Registry id
- NCT00036556
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.